Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | +17 |
| Ticker | DCTH |
| Latest Price | 12.69 USD as of close on 03-Jul-2025 |
| 3 Month price range | 10.39 to 18.10 USD |
| Market Capitalisation | 441.94Mn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Health Care Equipment & Services |
| Industry | Health Care Equipment & Supplies |
| Sub-Industry | Health Care Equipment |
| Description | Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1987 and is headquartered in New York, New York. See More ... |
| Company URL | https://www.delcath.com |
| See Darwins Full Analysis for Delcath Systems Inc |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Delcath Systems Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +13 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +3 |
| Flow | Institutional, Fund and Insider buying and selling. | +12 |
| Models | Forecast models. | -11 |
There are 6 peers of Delcath Systems Inc.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Co-Diagnostics Inc (CODX) | Health Care Equipment | -4.1 | +3 |
| Healthcare Triangle Inc (HCTI) | Health Care Equipment | +260.6 | -5 |
| Helius Medical Technologies Inc (HSDT) | Health Care Equipment | -94.3 | -33 |
| Nuwellis Inc (NUWE) | Health Care Equipment | -74.5 | -34 |
| PMGC Holdings Inc (ELAB) | Health Care Equipment | +1.4 | +1 |
| ReShape Lifesciences Inc (RSLS) | Health Care Equipment | -50.9 | -17 |
To see complete information on Delcath Systems Inc or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |